Telstar, new sponsors of ACE Foundation for the next three years

by Telstar

4 years ago
genetic, ACE Foundation, pharmaceutical, biotechnology, Alzheimer

Telstar, the consulting, engineering and projects company for the pharmaceutical and biotechnology sector, is committed to providing financial support for ACE Foundation projects over the next three y...

Galecto Announces Pricing of Initial Public Offering

by Ysios Capital

4 years ago
fibrotic, Galecto, biotechnology, cancer, GLTO, biological processes

Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company developing therapeutics that are designed to target the biological processes that lie at the heart of fibrosis and impact a broad r...

The Barcelona Science Park is committed to becoming Catalonia's MedTech company hub

by Parc Científic de Barcelona

4 years ago
PCB, GENESIS Biomed, MedTech, biomedicine, Catalonia, digital health, biotechnology

The Barcelona Science Park (PCB), a Spain's leading scientific, technological and business innovation hub in the life sciences field, aims to embark on a new phase of growth, offering more than 1,200 ...

Attending ASEBIO Investors Day, Online

by Oncoheroes Biosciences

4 years ago
biotechnology, ASEBIO Investor Day, Oncoheroes, event

Oncoheroes’ CEO, Ricardo Garcia, is attending Asebio Investor Day, a digital event organized by the “Asociación Española de Bioempresas“.

ORYZON First Half Ended June 30, 2020 Results and Corporate Update

by Oryzon Genomics

4 years ago
Oryzon, results, epigenetics, biotechnology, Iadademstat, Vafidemstat

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, today reported ...

A new mechanism of nature to break down carbohydrates

by Universitat de Barcelona

4 years ago
enzymes, carbohydrates, biotechnology, glycosidases, biomedicine

One of the basic processes of nature is the decomposition of organic matter, which requires the degradation of complex carbohydrate structures. To do so, it is necessary to break the long chains of...

Chemotargets one of the top-20 Spanish biotech companies to watch according to the technology magazine of the Financial Times

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

4 years ago
CLARITY platform, Chemotargets, biotechnology, pharmaceutical, Financial Times

This month Sifted, the technology magazine of the Financial Times, has contacted various experts in the technology industry and in analyzing data on investments, has concluded that the Spanish entrepr...

Biotechnology project to reduce mercury pollution in marine sediments

by Universitat Autònoma de Barcelona (UAB)

4 years ago
Biotechnology, mercury, marine sediments

The UAB participates in the MER-CLUB initiative to develop a technology based on the use of marine bacteria capable of degrading a toxic mercury compound that bio-accumulates in the trophic network. T...

Barcelona to host BIO-Europe Spring 2021

by Biocat

4 years ago
Barceloa, BIO-Europe Spring 2021, pharmaceutical industry, biotechnology

The main event for the European biopharmaceutical sector is coming back to the city after its success here in 2010, 2013 and 2017

Discovered the determining factors for the propulsion of microrobots

by IBEC - Institut de Bioenginyeria de Catalunya

5 years ago
microrobots, propulsion, enzyme, medicine, water treatment, biotechnology

A study led by researchers at the Institute for Bioengineering of Catalonia (IBEC) opens the door to moving new microscopic objects using an entire library of enzymes.

Minoryx Therapeutics extends its activities in Belgium

by Minoryx Therapeutics

5 years ago
Minoryx Therapeutics, subsidiary, biotechnology

Minoryx Therapeutics extends its activities in Belgium

Interview Valles Visio: Nanoligent

by Hospital de la Santa Creu i Sant Pau

5 years ago
Biotechnology, Biomedicine, drug, stem cells, metastatic

In June 2017, researchers from the IIB-Sant Pau, the Institute of Biotechnology and Biomedicine at the UAB and the CIBER-BBN, created a spin-off, Nanoligent, with the goal of developing the first drug...